eng URI http://hdl.handle.net/10795/2892 βιοχημεία καρκίνος πρόληψη των ασθενειών The extensive use of prostate-specific antigen as a general prostate cancer biomarker has introduced the hazards of overdiagnosis and overtreatment. Recent studies have revealed the immense biomarker capacity of microRNAs (miRNAs) in prostate cancer. The aim of this study was to analyze the expression pattern of miR-224, a cancer-related miRNA, in prostate tumors and investigate its clinical utility. 9 pp. LOMv1.0 creator LOMv1.0 publisher LOMv1.0 Scientific Coordinator LOMv1.0 Project Final Beneficiary LOMv1.0 Project Executing Organisation 2013 Digital Library of the Operational Programme "Education and Lifelong Learning" abstract types Text Prostate cancer miR-224 Molecular tumour markers Prognostic biomarker 594934 application/pdf http://repository.edulll.gr/edulll/bitstream/10795/2892/2/2892_Clin%20Chem.pdf URI http://hdl.handle.net/10795/2892 LOMv1.0creator 2016-04-25T11:31:14Z LOMv1.0validator 2016-04-25T11:31:14Z LOMv1.0 gre no no Copyright EYD-EPEDBM (Operational Programme "Education and Lifelong Learning")